3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is growing attracting clinical scrutiny due to limited evidence suggesting distinct physiological properties. Present studies indicate that https://www.pinterest.com/pin/1140888518124046392/